Press Releases – ADC Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

June 01, 2023

ADC Therapeutics to Participate in the Jefferies Healthcare Conference

May 11, 2023

ADC Therapeutics Announces Updated Results from LOTIS-2 Trial to be Presented at the European Hematology Association 2023 Hybrid Congress

May 10, 2023

ADC Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference

May 09, 2023

ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update

May 02, 2023

ADC Therapeutics to Host First Quarter 2023 Financial Results Conference Call on May 9, 2023

March 15, 2023

ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022

March 01, 2023

ADC Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

February 28, 2023

ADC Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

February 21, 2023

ADC Therapeutics to Host Fourth Quarter and Year-End 2022 Financial Results Conference Call on February 28, 2023

February 02, 2023

ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder

February 01, 2023

ADC Therapeutics to Participate in February Investor Conferences

January 04, 2023

ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer